Long-Term Debt: The sum of all long term debt fields.
Aldeyra Therapeutics, Inc. (ALDX) had Long-Term Debt of $15.10M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-9.93M |
|
-- |
|
-- |
|
$10.43M |
|
$-10.43M |
|
$0.50M |
|
$-9.93M |
|
$-9.93M |
|
$-9.93M |
|
$-9.93M |
|
$-9.93M |
|
$-9.93M |
|
$-10.43M |
|
$-10.78M |
|
59.89M |
|
59.89M |
|
$-0.17 |
|
$-0.17 |
|
| Balance Sheet Financials | |
$92.73M |
|
-- |
|
$0.47M |
|
$93.20M |
|
$14.29M |
|
|
Long-Term Debt |
$15.10M |
$15.31M |
|
$29.60M |
|
$63.60M |
|
$63.60M |
|
$63.60M |
|
60.05M |
|
| Cash Flow Statement Financials | |
$-12.47M |
|
$7.29M |
|
$1.00M |
|
$54.53M |
|
$50.35M |
|
$-4.18M |
|
$2.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.49 |
|
-- |
|
-- |
|
0.19 |
|
0.24 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.47M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.61% |
|
-15.61% |
|
-10.65% |
|
-12.62% |
|
$1.06 |
|
$-0.21 |
|
$-0.21 |
|